The Food and Drug Administration’s (FDA) advisory committee on vaccines this week will consider whether to change the COVID-19 vaccine to target the XFG subvariant for the upcoming 2026-2027 respiratory viral season. The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet on Thursday to discuss whether COVID-19 vaccines should target the NB.1.8.1…
FDA advisers to weigh updated COVID vaccine targeting XFG subvariant
Originally reported by The Hill. Read the full story at the original source.
Related Articles
Here are the District of Columbia's 2026 primary election results
Elections Here are the District of Columbia's 2026 primary election results June 16, 202612:01 AM ET By NPR S...
Supreme Court declines to hear gun industry challenge to NY law
The Supreme Court on Monday declined to hear a gun industry challenge to a New York law that allows lawsuits against gun...
Lawmakers caution Burgum, NPS they have ‘no power to build’ Trump’s arch
A group of six lawmakers sent a letter on Monday to Interior Secretary Doug Burgum, Acting Director of the National Park...
Trump says $300B fund to rebuild Iran is ‘Fake News’
President Trump on Monday sought to cast doubt on Iran getting $300 billion in reconstruction funding as part of a peace...